Navigation Links
Regado Biosciences, Inc. Presents Three Abstracts Pertaining to its Pipeline of Reversible Antithrombotic Agents, Including the Substudy Analyses of its Phase 2b RADAR Trial for REG1, its Lead Product Candidate, at the American Heart Association (AH
Date:11/14/2011

icaltrials.gov/">www.clinicaltrials.gov.

About Aptamers

Pegnivacogin is a member of a class of compounds called aptamers.  Aptamers are single stranded oligonucleotides that adopt a specific conformation enabling direct, specific inhibition of the targeted protein.   A key unique feature of aptamers derives from the fact that they are formed from nucleic acids.  As such, their pharmacologic activity can be controlled by a matched, complementary oligonucleotide active control agent (the Watson-Crick base pair complement of a fraction of the agent to be controlled), which can bind to the aptamer, removing it from its target and reversing its biologic effects.  Anivamersen is the active control agent of pegnivacogin.

More information can be found at www.regadobio.com

Contact:  Ellen McDonald, Chief Business Officer, Regado Biosciences, 1-908-580-2113, emcdonald@regadobio.com

Media Contact:
Tiberend Strategic Advisors, Inc.
1-212-827-0020
Andrew Mielach, amielach@tiberend.com

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


'/>"/>
SOURCE Regado Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Regado Biosciences, Inc. to Present at the Sofinnova Japan Biopharma Partnering Conference in Tokyo, Japan
2. Regado Biosciences to Present at the Annual UBS Global Life Sciences Conference in New York City
3. Regado Biosciences, Inc. Presents Results of the RADAR Phase 2b Clinical Trial of its REG1 Anticoagulation System
4. Regado Biosciences to Present at the Needham & Companys 10th Annual Healthcare Conference in New York City
5. Regado Biosciences, Inc. Announces Presentation of the Results of the RADAR Phase 2b Clinical Trial of Its Anticoagulant System REG1 at the i2 Summit During the American College of Cardiology 2011 60th Annual Scientific Session & Expo in New Orleans
6. Regado Biosciences to Present at the 2011 RBC Capital Markets Healthcare Conference in New York City
7. Regado Biosciences, Inc. Introduces REG3, a Novel Aptamer-Based Inhibitor of Glycoprotein VI and its Matched Active Control Agent, at the American Heart Association (AHA) Scientific Sessions 2010 Meeting
8. Regado Biosciences, Inc. Presents Pharmacokinetic and Pharmacodynamic (PK/PD) Substudy Results From its Phase 2b RADAR Trial at the American Heart Association (AHA) Scientific Sessions 2010 Meeting
9. Regado Biosciences, Inc. Presents Two Abstracts on the Subcutaneous Depot Formulation of Pegnivacogin, a Nuclease-Stabilized RNA Aptamer, Direct Factor IXa Inhibitor and Part of the REG2 Anticoagulant System, at the American Heart Association (AHA)
10. Regado Biosciences to Present at the IMPACT 2010 Conference in Philadelphia, Pennsylvania
11. Regado Biosciences, Inc. Presents the First-In-Human Clinical Experience with REG2 at the American College of Chest Physicians (ACCP) Coagulation and Heart Disease Sessions in Vancouver, BC, Canada on November 2, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... 23, 2014  Mezzion Pharma Co. Ltd., announced that ... use of udenafil to treat adolescents who have undergone ... The clinical program will follow protocols developed by a ... Network (PHN), a multi-center clinical research network funded by ... the National Institutes of Health (NIH). ...
(Date:7/23/2014)... 8,000 attendees will converge in Washington D.C. ... (RBC), taking place July 23-26 at the Gaylord National ... to "Lead Change" in the pharmacy profession, in their ... future. "RBC is the perfect opportunity for ... learn new ways they can lead change in healthcare ...
(Date:7/23/2014)... This September leading clinicians in orthodontics and ... for DOCtalk 2014 —a "Dynamic Orthodontic ... and private practitioner Dr. David Sarver , DOCtalk ... clinical and practice management efficiency and high quality patient ... to welcome fresh thinking and join a community of ...
Breaking Medicine Technology:Mezzion Pharma Initiates Clinical Development Program To Evaluate Udenafil In Adolescents With Single Ventricle Heart Defects 2Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 2Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 3Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 4Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 5Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 62014 DOCtalk Registration Now Open 22014 DOCtalk Registration Now Open 3
... N.M., June 3, 2011 Rep. Ed Whitfield, R-Ky., ... that will set federal minimum education and certification standards ... planning and delivering all medical imaging examinations and radiation ... Excellence ( CARE ) in Medical Imaging and Radiation ...
... 3, 2011 Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ... Sachs 32nd Annual Global Healthcare Conference on Wednesday, June 8, ... Interested parties may access a live webcast of ... It is recommended that listeners log on ...
Cached Medicine Technology:Medical Imaging and Radiation Therapy Personnel Certification Bill Introduced in Congress 2Medical Imaging and Radiation Therapy Personnel Certification Bill Introduced in Congress 3Onyx Pharmaceuticals to Present at the Goldman Sachs 32nd Annual Global Healthcare Conference 2
(Date:7/23/2014)... the University of Exeter has developed a simple, ... frequently fatal lung disease which attacks immune deficient ... transplant recipients. , The lateral-flow device (LFD), created ... a notoriously difficult to diagnose disease caused by ... , Invasive aspergillosis is a leading cause of ...
(Date:7/23/2014)... Randy Dotinga HealthDay Reporter ... A powerful drug combo may not be as effective ... on human cells suggests that one of the medications ... this study,s findings aren,t definitive, and there,s still hope ... and lumacaftor, according to the study,s senior author. ...
(Date:7/23/2014)... 23, 2014 Home Care Assistance ... for seniors, is proud to announce the next installment ... in a wide range of health and wellness-related fields. ... and award-winning author Nancy Kriseman, and will cover the ... prevent burnout by becoming more self-aware. In particular, Nancy ...
(Date:7/23/2014)... in Shaanxi province, and the University of California, Davis, ... groundwork for establishing the Sino-U.S. Joint Research Center for ... held in the city of Yingchuan, China, during a ... Agriculture and China,s Ministry of Science and Technology. , ... and for our World Food Center and serves as ...
(Date:7/23/2014)... Thousands of DePuy Pinnacle hip lawsuits ... federal multidistrict litigation underway in U.S. District Court, Northern ... an Order dated July 18th, U.S. District Judge Ed ... a $1,000 fee for the preservation and return of ... things, the Order noted that there is no evidence ...
Breaking Medicine News(10 mins):Health News:New device detects deadly lung disease 2Health News:Cystic Fibrosis Drug Combo May Be Less Effective Than Hoped 2Health News:Cystic Fibrosis Drug Combo May Be Less Effective Than Hoped 3Health News:Home Care Assistance Calgary to Host Public Webinar on the Topic of Caregiver Mindfulness 2Health News:Home Care Assistance Calgary to Host Public Webinar on the Topic of Caregiver Mindfulness 3Health News:Global food safety research agreement signed by China and UC Davis 2Health News:Global food safety research agreement signed by China and UC Davis 3Health News:DePuy Pinnacle Hip Lawsuits Move Forward, as Federal Judge Denies Hospital Bid for $1000 Explant Fee, Bernstein Liebhard LLP Reports 2Health News:DePuy Pinnacle Hip Lawsuits Move Forward, as Federal Judge Denies Hospital Bid for $1000 Explant Fee, Bernstein Liebhard LLP Reports 3Health News:DePuy Pinnacle Hip Lawsuits Move Forward, as Federal Judge Denies Hospital Bid for $1000 Explant Fee, Bernstein Liebhard LLP Reports 4
... women in the United States will have an osteoporosis-related fracture ... published in the May 2010 issue of the Journal ... a few of these women will be tested and treated ... their risk of future fractures. "Less than 10 percent ...
... ... Affiliates Medical Group, a Torrance, California-based healthcare organization, today announced the acquisition of ... 67,000 managed care patients in Los Angeles County and Orange County, California. ... Torrance, ...
... friends and good communication are key, study finds , ... an important role in preventing their children from becoming ... know their friends, a new study suggests. , ... could have a substantial impact on child bullying," said ...
... A new study shows that a family of molecules ... control many important functions in healthy cells, but that ... , The research, led by scientists at the ... Hospital and Richard J. Solove Research Institute in collaboration ...
... feel that their Government has managed the financial crisis quite well. ... two of the findings presented in a new report by the ... of what may be the worst financial crisis since the 1930s, ... in a new SOM report presented Tuesday at a seminar at ...
... Best practices for managing medical emergencies in dental clinics ... advances in knowledge and the development of new medications ... School of Dental Medicine and an expert on dental ... an updated list of emergency medications and equipment for ...
Cached Medicine News:Health News:Women want answers, but what questions should be asked? 2Health News:Women want answers, but what questions should be asked? 3Health News:HealthCare Partners Medical Group Expands to Orange County. HealthCare Partners and Talbert Medical Group Join Forces 2Health News:HealthCare Partners Medical Group Expands to Orange County. HealthCare Partners and Talbert Medical Group Join Forces 3Health News:Involved Parents Less Likely to Raise Bullies 2Health News:Cancer cells show rewired, fragmented microRNA networks 2Health News:Swedes think highly of the government -- but not of the royal family 2Health News:New emergency preparedness information available for dental offices 2
... ACONO H. pylori Rapid Test Strip and ... qualitative detection of antibodies to Helicobacter pylori ... plasma to aid in the diagnosis of ... of age and older. They are intended ...
... is a lateral-flow immuno-chromatographic assay intended for ... specific to Helicobacter pylori in human serum, ... convenient, non-invasive, and easy to perform test ... of H.pylori infection in patients with clinical ...
... The Trinity Biotech Uni-Gold™ H. ... rapid, in vitro qualitative detection of ... pylori) in adult human serum, plasma ... in the diagnosis of H. pylori ...
... FDA approved rapid point-of-care fingerstick ... used to aid in the ... CLIA waived test, which detects ... HIV-1, requires only a drop ...
Medicine Products: